Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-9.98	66.19	73.53
Graham Fair Price	8.75	28.34	26.06
PEG	-62.88	1.75	4.73
Price/Book	3.22	4.51	4.37
Price/Cash Flow	-57.10	38.84	90.53
Prices/Earnings	-6.42	25.52	27.27
Price/Sales	5.24	15.90	15.11
Price/FCF	-57.10	38.84	90.53
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-34.51	0.24	0.37
Operating Margin	14.08	0.22	0.19
ROA	6.86	0.03	0.02
ROE	0.04	0.04	10.31
ROIC	0.03	0.03	-15.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.01	< 0.005	583.28
Dividends QOQ	< 0.005	< 0.005	-71.43
EBIT QOQ	0.07	0.16	133.00
EPS QOQ	0.06	0.15	152.12
FCF QOQ	-0.24	1.50	518.97
Revenue QOQ	0.09	0.02	-80.70
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	262.64	0.00	inf
Days Sales Outstanding (DSO)	63.36	40.20	-36.55
Inventory Turnover	0.34	0.00	inf
Debt/Capitalization	0.19	0.39	101.43
Quick Ratio	1.29	1.10	-14.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	27.47	28.44	3.54
Cash	8.71	11.30	29.72
Capex	-0.24	-0.19	21.75
Free Cash Flow	1.32	3.30	149.11
Revenue	7.94	8.06	1.56
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.29	1.32	2.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.31	-2.55	-93.94
Naive Interpretation	Member

06 - Financial Health · Weak

Rating